Prostate Cancer - Results from #24780

Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration resistant prostate cancer: Results from the University of Washington rapid autopsy series - Abstract September 24, 2012

Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry - Abstract September 24, 2012

Diabetic nephropathy is associated with prostate-specific antigen levels in type 2 diabetes mellitus - Abstract September 24, 2012

The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety - Abstract September 21, 2012

20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer - Abstract September 21, 2012

Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer - Abstract September 21, 2012

Review of hypofractionated radiotherapy for prostate cancer - Abstract September 21, 2012

Sequencing of cabazitaxel in metastatic castrate-resistant prostate cancer: A case report - Abstract September 21, 2012

A comparison of virtual touch tissue quantification and digital rectal examination for discrimination between prostate cancer and benign prostatic hyperplasia - Abstract September 21, 2012

Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: Efficacy and safety of denosumab - Abstract September 21, 2012

Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer: Matched-pair analysis - Abstract September 21, 2012

HPV persistence and its oncogenic role in prostate tumors - Abstract September 21, 2012

Prostate cancer in African American men: Making awareness a priority, a community-based effort September 20, 2012

Author Andrea King Colliers adds humor and a woman’s perspective to men's health issues September 20, 2012

Prostate Education Program (PEP): Inspired pep talks from the Black Barbershop Health Outreach Program Advocate, Stanley K. Frencher, MD, MPH September 20, 2012

Charlie Wilson brings the message home: “Don’t be afraid to talk about prostate cancer.” September 20, 2012

Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner - Abstract September 20, 2012

MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: Initial feasibility in humans - Abstract September 20, 2012

Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer - Abstract September 20, 2012

Factors associated with satisfaction with prostate cancer care: Results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) - Abstract September 20, 2012

Page 1240 of 1437